Sr. Principal Process Engineer - Small Molecule (NOT REMOTE - NEW SITE) at Eli Lilly and Company

Chester, Maryland, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Candidates must possess a Bachelor's Degree in Process, Chemical, Biochemical Engineering, or a related STEM discipline, coupled with over 5 years of experience in API Manufacturing Unit Operations. Additional preferences include experience with API chemical synthesis and biotech unit operations like chromatography, a strong understanding of GMP production environments, and a solid foundation in Chemical Engineering. The ability to think analytically, solve problems, work both independently and collaboratively, coach others, and adapt to changing business needs is essential.

Responsibilities

The Senior Principal Process Engineer will provide technical leadership in small molecule or peptide manufacturing, mentor process engineers, and sustain process knowledge. Key duties include supporting equipment and process optimization, managing engineering systems and assets, promoting data-driven decision-making, supporting root cause analyses, identifying and addressing process knowledge gaps, and maintaining process safety foundations. The role also involves ensuring equipment qualification, integrating modeling and simulation, driving continuous improvement, leading tech transfers, guiding user requirements and design reviews, and advising on return-to-service protocols.

Skills

Process Engineering

Small Molecule Manufacturing

Peptide Manufacturing

API Manufacturing

GMP

Root Cause Analysis

Statistical Methods

First Principles

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free